Question of the Day – Monday June 28, 2021
Name the plant. Podophyllum peltatum Personal image credit to Dr. Michael Hodgman. Verified by PictureThis™
Question of the Day – Friday June 25, 2021
Name the plant. Common Comfrey (Symphytum officinale) Personal image credit to Dr. Robert Bennet. Verified by PictureThis™
Question of the Day – Thursday June 24, 2021
Lacosamide has been shown to cause a dose dependent increase of this interval on the ECG? PR interval. Lacosamide has been shown to cause a dose dependent prolongation of the PR interval with a mean prolongation of 4.2 msec to 12.3 msec at 400 mg/day….
Question of the Day – Wednesday June 23, 2021
Is acute kidney injury associated with a higher mortality in poisoned patients? Vodovar et al. recently sought to determine whether poisoned patients who develop acute kidney injury have higher mortality compared to those who did not. While all three consensus definitions were independently associated with…
Question of the Day – Tuesday June 22, 2021
In a recent study, this formulation of marijuana was more likely to result in serious medical outcomes? a. Plant materials b. Edibles c. Concentrates d. Vaporized liquids D. Vaporized Liquids. In a recent cross sectional study utilizing NPDS data on cannabis exposures, vaporized liquid exposures…
Question of the Day – Monday June 21, 2021
What is the clinical triad of chronic ketamine abuse? Obstructive uropathy, cholestasis, pneumomediastinum Ferraz de Oliveira I,Mesland JB, Laterre PF, Hantson P. Triad of obstructive uropathy, cholestasis, and pneumomediastinum associated with chronic ketamine abuse: a case report. Toxicology Communications 2021; 5(1);115-118. DOI: 10.1080/24734306.2021.1925443 Submitted by:…
Question of the Day – Friday June 18, 2021
Naloxone hydrochloride nasal spray to treat opioid overdose has recently received FDA approval in what dose? In addition to the previously approved 2-mg and 4-mg doses, an 8-mg spray will be available. Voelker R. New naloxone dosage is approved. JAMA. 2021;325(21):2143. doi:10.1001/jama.2021.8320
Question of the Day – Thursday June 17, 2021
A recent letter to the editor described successful treatment of anticholinergic delirium (ACD) with this acetylcholinesterase inhibitor during a physostigmine drug shortage. Rivastigmine. According to the cited reference, in a patient with severe ACD, “therapy with 1.5 mg rivastigmine po twice daily was started. This…
Question of the Day – Wednesday June 16, 2021
A recent retrospective cohort analysis examined the incidence of short-term graft failures of all transplanted individual organs reported to one US procurement organization over a 17-month period. How did the rates of short-term graft failures compare between organs procured from patients with drug-related death versus…
Question of the Day – Tuesday June 15, 2021
A recent prospective, open label, randomized controlled trial found that this medication is a potential alternative to naloxone for reversal of methadone, a long acting opioid. IV buprenorphine. This study randomized patients with methadone-induced respiratory depression to receive naloxone (titrated doses), or lower or higher…